ENTITY
Grifols SA

Grifols SA (GRF SM)

95
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullish•Grifols SA
•17 Sep 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: September '26 Report

September brought fresh dispersion: Carlsberg, Grifols and MFE widened sharply, improving convergence returns, while Ericsson's B-only buyback adds...

Share
•17 Aug 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: August '26 Report

August brought fresh dispersion across Europe's dual-class shares, creating new relative-value opportunities while corporate actions remain an...

Share
•16 Jul 2026 17:02

Liquid Universe of European Ordinary and Preferred Shares: July '26 Report

-July widened dispersion across Europe’s dual-class universe, yet selective convergence persisted beneath the surface. Structural anomalies...

Share
•17 Jun 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: June '26 Report

June brought renewed divergence across European ord/pref pairs. Structural outliers widened, convergence became more selective, and implementation...

Share
•12 Aug 2019 09:31

Global Equity Strategy: Another Test of Support

Heightened trade tensions have caused global equities to move from resistance to support in a matter of days. Additional consolidation - i.e., no...

Logo
546 Views
Share
x